info@invisionmedi.com
Zeromet 500 SR Tablets
Smoothens Life by Controlling Diabetes
COMPOSITION – Metformin HCL IP IP 500 mg
Description
Endocrinologists/American College of Endocrinology (AACE/ACE) recommend early initiation of metformin as a first-line drug for monotherapy and combination therapy for patients with T2DM.
Metformin is primarily used for the treatment of type 2 diabetes mellitus, particularly in obese patients. Metformin has been shown to reduce diabetes mortality and complications by thirty percent compared to insulin, glibenclamide, and chlorpropamide.
Metformin
- Drug class: Biguanides
- Metformin’s negligible risk of hypoglycemia in monotherapy and few drug interactions of clinical relevance give this drug a high safety profile.
- Useful in reducing postprandial hyperglycemia.
- The insulin sensitizer, Metformin, is mainly used in subjects with type 2 diabetes who are obese.
Indications
- Type 2 Diabetes(NIDDM)
- Hyperglycaemia
- Diabetic Dyslipidemia
Composition
- Metformin HCL IP IP 500 mg
Related products
-
GLAMOR-P Tablets
Fight Diabetes by Improving the Good Cholesterol COMPOSITION – Glimepiride IP 2 mg + Pioglitazone Hydrochloride 15 mg Tabs.
-
GLATIX-M & M-80 Tablets
Avert Heart Diseases by Managing Diabetes COMPOSITION – Glatix-M: Gliclazide 40 mg + Metformin HCI 500 mg Glatix-80: Gliclazide 80 mg + Metformin HCI 500 mg
-
V-BOSE-GM2 – Tablets
An Abiding Antidiabetic combination for coherent Diabetic Control COMPOSITION – Glimepiride IP 2 mg+ Voglibose 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)
-
V-BOSE-0.2/ 0.3 Tablets
Limiting Hyperglycemia without Compromising Hypoglycemia COMPOSITION – Voglibose IP 0.2 Voglibose IP 0.3